CYCC
Price
$8.98
Change
+$0.17 (+1.93%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
13.95M
PROK
Price
$2.25
Change
-$0.33 (-12.74%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
345.56M
99 days until earnings call
Interact to see
Advertisement

CYCC vs PROK

Header iconCYCC vs PROK Comparison
Open Charts CYCC vs PROKBanner chart's image
Cyclacel Pharmaceuticals
Price$8.98
Change+$0.17 (+1.93%)
Volume$1.44K
Capitalization13.95M
ProKidney
Price$2.25
Change-$0.33 (-12.74%)
Volume$47.31K
Capitalization345.56M
CYCC vs PROK Comparison Chart in %
Loading...
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCC vs. PROK commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCC is a Buy and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (CYCC: $8.78 vs. PROK: $2.59)
Brand notoriety: CYCC and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCC: 5% vs. PROK: 13%
Market capitalization -- CYCC: $13.95M vs. PROK: $345.56M
CYCC [@Biotechnology] is valued at $13.95M. PROK’s [@Biotechnology] market capitalization is $345.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCC’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • CYCC’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, both CYCC and PROK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCC’s TA Score shows that 4 TA indicator(s) are bullish while PROK’s TA Score has 5 bullish TA indicator(s).

  • CYCC’s TA Score: 4 bullish, 6 bearish.
  • PROK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PROK is a better buy in the short-term than CYCC.

Price Growth

CYCC (@Biotechnology) experienced а -9.67% price change this week, while PROK (@Biotechnology) price change was -8.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($346M) has a higher market cap than CYCC($13.9M). PROK YTD gains are higher at: 53.254 vs. CYCC (-90.270). PROK has more cash in the bank: 328M vs. CYCC (93K). CYCC has less debt than PROK: CYCC (9K) vs PROK (3.37M).
CYCCPROKCYCC / PROK
Capitalization13.9M346M4%
EBITDAN/A-160.12M-
Gain YTD-90.27053.254-170%
P/E Ratio0.20N/A-
RevenueN/A306K-
Total Cash93K328M0%
Total Debt9K3.37M0%
FUNDAMENTALS RATINGS
CYCC: Fundamental Ratings
CYCC
OUTLOOK RATING
1..100
98
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYCCPROK
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
68%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
62%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
72%
Advances
ODDS (%)
Bullish Trend 19 days ago
82%
Bullish Trend 11 days ago
73%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
65%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DEMCF0.220.02
+9.00%
Discovery Energy Metals Corp.
SNEJF27.390.31
+1.16%
Sony Group Corporation
CPCAF1.51N/A
N/A
Cathay Pacific Airways, Ltd.
BKUTK499.00N/A
N/A
Bank of Utica (NY)
NNWWF35.11-0.03
-0.09%
North West Company, Inc. (The)

CYCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYCC has been loosely correlated with PROK. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CYCC jumps, then PROK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCC
1D Price
Change %
CYCC100%
-2.12%
PROK - CYCC
57%
Loosely correlated
+0.97%
JSPR - CYCC
36%
Loosely correlated
-10.26%
MTVA - CYCC
26%
Poorly correlated
-1.01%
HOWL - CYCC
24%
Poorly correlated
-0.85%
RLYB - CYCC
22%
Poorly correlated
+3.91%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with CYCC. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+0.97%
CYCC - PROK
57%
Loosely correlated
-2.12%
RLYB - PROK
45%
Loosely correlated
+3.91%
LGVN - PROK
45%
Loosely correlated
-46.62%
NRIX - PROK
39%
Loosely correlated
-2.28%
APGE - PROK
38%
Loosely correlated
-1.69%
More